Diversity Reboot Summit

Bristol Myers Squibb Commitment to Addressing Health Disparities and Diversity

This event has ended. You can watch the recording here.
Virtual
Bristol Myers Squibb Commitment to Addressing Health Disparities and Diversity

Bristol Myers Squibb recognizes and celebrates the diverse experiences and views of their workforce. They encourage every employee to bring their authentic selves to work so they can fully engage in a meaningful way and drive the company's mission to help patients prevail over serious diseases. Bristol Myers Squibb's PRIDE Alliance is a vital part of that effort, helping to ensure a diverse and inclusive culture that empowers LGBTQ+ inclusion, awareness, and engagement. For this roundtable discussion we are joined by several BMS leaders to share their career journeys and take a deep dive into BMS's Heath Equity approach and work including how how prior partnerships with HIV and LGBTQ+ communities became the playbook for the current initiatives. PowerToFly's Meg Alexander will moderate.

Meet The Speakers

Patricia Mae Doykos, PhD
Patricia Mae Doykos, PhD
Sr. Director, BMS Foundation, Bristol Myers Squibb

Patricia “Patti” Mae Doykos is Executive Director of Health Equity at Bristol Myers Squibb. In this newly created role, Patti leads internal and external health equity efforts across the organization to deliver the best outcomes for medically underserved patient populations.

Patti has 23 years of experience and leadership in transformative corporate philanthropy and corporate social responsibility, product brand and strategic communications, and health equity and social justice at BMS. Most recently, she served as Director of the Bristol Myers Squibb Foundation since 2002. In January 2020, she took on the role of lead for BMS’s Health Equity Initiative to develop and implement an enterprise-wide health equity approach and strategy. Previously, Patti has developed and led U.S. and international grant-making and public-private partnership programs for global HIV/AIDS, women’s health, diabetes, serious mental illness, cancer, immunology, and COVID-19.

Among her current service roles are inaugural chair of the board of the Center for Global Health Equity at Dartmouth-Geisel Medical School, Board of Advisors for Dartmouth-Geisel Medical School, Advisory Board of the Center for Global Health at Rutgers University, and Trustee of Phillips Academy Andover and member of its Anti-Racism Task Force.

Feyikemi Osundina, PharmD, MS
Feyikemi Osundina, PharmD, MS
Associate Director, Health Equity & New Partnerships at Bristol Myers Squibb
Passionate, innovative, and collaborative leader with experience in outcomes research, global public health, and biopharmaceutical advocacy relations. My intention as a devoted advocate to the organizations I work with is to develop authentic partnerships that enhance health, hope, and life for communities affected by serious disease. My passion is identifying innovative health equity solutions and cross-organizational collaborations that incorporate the patient voice into transformative research. In my current role, I am responsible for supporting the implementation of BMS’s Health Equity patient advocacy strategy and relationships across BMS’s therapeutic areas (oncology, hematology, cardiovascular & immunology). Through collaborations with advocacy stakeholders invested in health equity and various internal matrix teams, I work to evaluate opportunities and develop unique solutions to ensure that diverse populations have access to care and that their voices are heard and understood across BMS research, development, and commercial product phases. Proven track record of delivering on shared goals and advancing business performance. Strengths and capabilities in: • Creating and fostering intentional and impactful advocacy partnerships • Driving innovative health equity solutions (ex. Patient Reported Outcomes, Clinical Trial Diversity, and Patient Engagement) • Cross-matrix project management to incorporate diverse patient voices while advancing business performance • Brand positioning & portfolio awareness related to launch execution
Paul Shay
Paul Shay
Lead: People and Business Resource Group (PBRG) PRIDE Alliance at Bristol-Myers Squibb
Innovative Biopharmaceutical strategy leader with consulting and operations experience. Strong track record of leveraging trends and insights to develop business strategies, and leading teams and organizations to the successful implementation of business-enhancing initiatives. Experience includes familiarity with US and ex-US markets, Commercial and R&D organizations, and having impact in start-up and large company environments. Recognized for analyzing complex information and uncovering insights to develop strategic recommendations and results. Effective relationship builder that fosters credibility through accountability and collaboration.